Molina Healthcare, Inc. cash flow to debt ratio of -13.54% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Molina Healthcare, Inc.'s free cash flow has decreased -216.91% from $544.00M last year to $-636.00M, signaling decreasing performance

Molina Healthcare, Inc.'s debt to equity ratio is 0.97, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Molina Healthcare, Inc.'s debt has increased relative to shareholder equity from 0.69 last year to 0.97 today, signaling weakened financials

Molina Healthcare, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Molina Healthcare, Inc.'s interest coverage ratio of 2.58 indicates that earnings with margin can cover interest payments on company debt

Molina Healthcare, Inc.'s profit margin has decreased (-85.62%) in the last year from 2.90% to 0.42%, signaling decreasing performance

Molina Healthcare, Inc.'s short-term assets of $12.44G exceed its short-term liabilities of $7.37G

Molina Healthcare, Inc.'s return on assets of 1.15% is lower than the 5.00% threshold, indicating inefficient asset utilization

Molina Healthcare, Inc.'s return on equity of 4.44%, is lower than 15.00%, indicating bad performance

Molina Healthcare, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Molina Healthcare, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

Molina Healthcare, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Molina Healthcare, Inc. has negative free cash flow, indicating cash burn

Molina Healthcare, Inc.'s yearly earnings has decreased -59.97% since last year from $1.18G to $472.00M, signaling decreasing performance

Molina Healthcare, Inc.'s yearly revenue has increased 11.75% since last year from $40.65G to $45.43G, signaling increasing performance

ROIC 5.27% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Molina Healthcare, Inc.'s 3-year revenue CAGR of 12.42% is positive, indicating growing revenue over the past 3 years

Molina Healthcare, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Molina Healthcare, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity

Molina Healthcare, Inc. has insufficient data to evaluate this check.

Molina Healthcare, Inc. has an earnings yield of 1.53%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Molina Healthcare, Inc. is overvalued relative to its fair value price of 136.88 based on EBITDA multiple model

Molina Healthcare, Inc. has an EV/EBITDA ratio of 12.59x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Molina Healthcare, Inc. is undervalued relative to its fair value price of 725.25 based on Earnings Fair Value model

Molina Healthcare, Inc. has no meaningful EPS growth rate; PEG ratio cannot be computed.

Molina Healthcare, Inc. has a price-to-book ratio of 3.02x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Molina Healthcare, Inc. has a price-to-sales ratio of 0.27x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue